Skip to main content
Top
Published in: European Child & Adolescent Psychiatry 8/2018

01-08-2018 | Original Contribution

Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive–compulsive disorder

Authors: Rukiye Çolak Sivri, Ayhan Bilgiç, İbrahim Kılınç

Published in: European Child & Adolescent Psychiatry | Issue 8/2018

Login to get access

Abstract

The aim of this study was to investigate whether the serum levels of IL-12, IL-17, TGFβ, TNF-alpha, sTNFR1, sTNFR2, IL-1β, CCL3, CCL24, CXCL8, and BDNF are associated with obsessive–compulsive disorder (OCD) in medication-free children. A total of 44 (22 boys/22 girls) medication-free children with OCD and 40 (23 boys/17 girls) healthy controls were included in this study. The severity of the OCD symptoms were assessed by the Children’s Yale–Brown Obsessive–Compulsive Scale and the Maudsley Obsessive–Compulsive Inventory. The Children’s Depression Inventory and the Screen for Child Anxiety-Related Emotional Disorders were applied to the children in order to determine depression and anxiety levels. IL-17, IL-12, TGF β, TNF-alpha, sTNFR1, sTNFR2, IL-1β, CCL3, CCL24, CXCL8, and BDNF levels were measured by enzyme-linked immunosorbent assay. Multivariate analysis of covariance (MANCOVA) revealed a significant main effect on both groups for the levels of serum cytokine, chemokine, and BDNF, an effect that was independent of severities of depression and anxiety [Pillai’s Trace V = 0.371, F (11, 70) = 3.756, p < 0.001, hp2 = 0.187]. Analysis of covariance (ANCOVA) indicated that serum TNF-alpha levels were significantly higher in the OCD group than in the control group (p < 0.001). In contrast, serum IL-12 levels were significantly lower in the OCD group than in the control group (p = 0.014). These findings suggest that TNF-alpha and IL-12 may play a role in the pathophysiology of OCD in children. The causal relationship between these proinflammatory cytokines and pediatric OCD requires further investigation.
Literature
1.
go back to reference Bipeta R, Yerramilli SS, Pingali S, Karredla AR, Ali MO (2013) A crosssectional study of insight and family accommodation in pediatric obsessive-compulsive disorder. Child Adolesc Psychiatry Ment Health 7:20CrossRefPubMedPubMedCentral Bipeta R, Yerramilli SS, Pingali S, Karredla AR, Ali MO (2013) A crosssectional study of insight and family accommodation in pediatric obsessive-compulsive disorder. Child Adolesc Psychiatry Ment Health 7:20CrossRefPubMedPubMedCentral
2.
go back to reference Thomsen PH (2013) Obsessive–compulsive disorders. Eur Child Adolesc Psychiatry 22:23–28CrossRef Thomsen PH (2013) Obsessive–compulsive disorders. Eur Child Adolesc Psychiatry 22:23–28CrossRef
4.
go back to reference Oliveira S, Pelajo C (2010) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): a controversial diagnosis. Curr Infect Dis Rep 12:103–109CrossRefPubMed Oliveira S, Pelajo C (2010) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): a controversial diagnosis. Curr Infect Dis Rep 12:103–109CrossRefPubMed
5.
go back to reference Rocha FF, Correa H, Teixeira AL (2008) Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry 32:1139–1146CrossRefPubMed Rocha FF, Correa H, Teixeira AL (2008) Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry 32:1139–1146CrossRefPubMed
6.
go back to reference Mitchell RCB, Goldstein BI (2014) Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J Am Acad Child Adolesc Psychiatry 53:274–296CrossRefPubMed Mitchell RCB, Goldstein BI (2014) Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J Am Acad Child Adolesc Psychiatry 53:274–296CrossRefPubMed
7.
go back to reference Brambilla F, Perna G, Bellodi L, Arancio C, Bertani A, Perini G, Carraro C, Gava F (1997) Plasma interleukin-1β and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry 42:976–981CrossRefPubMed Brambilla F, Perna G, Bellodi L, Arancio C, Bertani A, Perini G, Carraro C, Gava F (1997) Plasma interleukin-1β and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry 42:976–981CrossRefPubMed
8.
go back to reference Monteleone P, Catapano F, Fabrazzo M, Tortorella A, Maj M (1998) Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology 37:182–185CrossRefPubMed Monteleone P, Catapano F, Fabrazzo M, Tortorella A, Maj M (1998) Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology 37:182–185CrossRefPubMed
9.
go back to reference Denys D, Fluitman S, Kavelaars A, Heijnen C, Westenberg H (2004) Decreased TNF-α and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology 29:945–952CrossRefPubMed Denys D, Fluitman S, Kavelaars A, Heijnen C, Westenberg H (2004) Decreased TNF-α and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology 29:945–952CrossRefPubMed
10.
go back to reference Konuk N, Tekin IO, Ozturk U, Atik L, Atasoy N, Bektas S, Erdogan A (2007) Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm 2007:65704CrossRefPubMedPubMedCentral Konuk N, Tekin IO, Ozturk U, Atik L, Atasoy N, Bektas S, Erdogan A (2007) Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm 2007:65704CrossRefPubMedPubMedCentral
11.
go back to reference Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Krönig H et al (2005) Increasedserum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette’s syndrome. Biol Psychiatry 57:667–673CrossRefPubMed Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Krönig H et al (2005) Increasedserum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette’s syndrome. Biol Psychiatry 57:667–673CrossRefPubMed
12.
go back to reference Matz J, Krause DL, Dehning S, Riedel M, Gruber R, Schwarz MJ, Müller N (2012) Altered monocyte activation markers in Tourette’s syndrome: a case-control study. BMC Psychiatry 12:29CrossRefPubMedPubMedCentral Matz J, Krause DL, Dehning S, Riedel M, Gruber R, Schwarz MJ, Müller N (2012) Altered monocyte activation markers in Tourette’s syndrome: a case-control study. BMC Psychiatry 12:29CrossRefPubMedPubMedCentral
13.
go back to reference Bos-Veneman NG, Bijzet J, Limburg PC, Minderaa RB, Kallenberg CG, Hoekstra PJ (2010) Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder. Prog Neuropsychopharmacol Biol Psychiatry 34:1390–1395CrossRefPubMed Bos-Veneman NG, Bijzet J, Limburg PC, Minderaa RB, Kallenberg CG, Hoekstra PJ (2010) Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder. Prog Neuropsychopharmacol Biol Psychiatry 34:1390–1395CrossRefPubMed
14.
go back to reference Gabbay V, Coffey BJ, Guttman LE, Gottlieb L, Katz Y, Babb JS, Hamamoto MM, Gonzalez CJ (2009) A cytokine study in children and adolescents with Tourette’s disorder. Neuropsychopharmacol Biol Psychiatry 33:967–971CrossRef Gabbay V, Coffey BJ, Guttman LE, Gottlieb L, Katz Y, Babb JS, Hamamoto MM, Gonzalez CJ (2009) A cytokine study in children and adolescents with Tourette’s disorder. Neuropsychopharmacol Biol Psychiatry 33:967–971CrossRef
15.
go back to reference Şimşek Ş, Gençoğlan S, Yüksel T, Kaplan İ, Alaca R (2016) Cortisol and brain-derived neurotrophic factor levels prior to treatment in children with obsessive-compulsive disorder. J ClinPsychiatry 77:855–859 Şimşek Ş, Gençoğlan S, Yüksel T, Kaplan İ, Alaca R (2016) Cortisol and brain-derived neurotrophic factor levels prior to treatment in children with obsessive-compulsive disorder. J ClinPsychiatry 77:855–859
16.
go back to reference Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am Psychiatry 157:683–694CrossRef Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am Psychiatry 157:683–694CrossRef
17.
go back to reference Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL (2012) A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry 53:797–804CrossRefPubMed Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL (2012) A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry 53:797–804CrossRefPubMed
18.
go back to reference Liu S, Liu Y, Yin Y, Zhang X, Ma X (2012) A case-control study of interleukin-12 1188A/C polymorphism in obsessive-compulsive disorder in Chinese population. Acta Neuropsychiatr 24:172–175CrossRefPubMed Liu S, Liu Y, Yin Y, Zhang X, Ma X (2012) A case-control study of interleukin-12 1188A/C polymorphism in obsessive-compulsive disorder in Chinese population. Acta Neuropsychiatr 24:172–175CrossRefPubMed
19.
go back to reference Maes M, Meltzer HY, Bosmans E (1994) Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. Neuropsychobiology 30:57–60CrossRefPubMed Maes M, Meltzer HY, Bosmans E (1994) Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. Neuropsychobiology 30:57–60CrossRefPubMed
20.
go back to reference Takatori H, Kanno Y, Chen Z, O’Shea JJ (2008) New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod Rheumatol 18:533–541CrossRefPubMedPubMedCentral Takatori H, Kanno Y, Chen Z, O’Shea JJ (2008) New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod Rheumatol 18:533–541CrossRefPubMedPubMedCentral
21.
go back to reference Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M et al (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173–1175CrossRefPubMedPubMedCentral Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M et al (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173–1175CrossRefPubMedPubMedCentral
22.
go back to reference Frydecka D, Misiak B, Beszlej JA, Karabon L, Pawlak-Adamska E, Tomkiewicz A, Jonkisz A, Kiejna A (2013) Genetic variants in transforming growth factor-beta gene (TGFB1) affect susceptibility to Schizophrenia. Mol Biol Rep 40:5607–5614CrossRefPubMedPubMedCentral Frydecka D, Misiak B, Beszlej JA, Karabon L, Pawlak-Adamska E, Tomkiewicz A, Jonkisz A, Kiejna A (2013) Genetic variants in transforming growth factor-beta gene (TGFB1) affect susceptibility to Schizophrenia. Mol Biol Rep 40:5607–5614CrossRefPubMedPubMedCentral
23.
go back to reference Davami MH, Baharlou R, Ahmadi Vasmehjani A, Ghanizadeh A, Keshtkar M, Dezhkam I, Atashzar MR (2016) Elevated IL-17 and TGF-β serum levels: a positive correlation between T-helper 17 cell-related pro-inflammatory responses with major depressive disorder. Basic Clin Neurosci 7:137–142PubMedPubMedCentral Davami MH, Baharlou R, Ahmadi Vasmehjani A, Ghanizadeh A, Keshtkar M, Dezhkam I, Atashzar MR (2016) Elevated IL-17 and TGF-β serum levels: a positive correlation between T-helper 17 cell-related pro-inflammatory responses with major depressive disorder. Basic Clin Neurosci 7:137–142PubMedPubMedCentral
24.
go back to reference Li H, Hong W, Zhang C, Wu Z, Wang Z, Yuan C, Li Z, Huang J, Lin Z, Fang Y (2015) IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode. J Affect Disord 174:361–366CrossRefPubMed Li H, Hong W, Zhang C, Wu Z, Wang Z, Yuan C, Li Z, Huang J, Lin Z, Fang Y (2015) IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode. J Affect Disord 174:361–366CrossRefPubMed
25.
go back to reference Şimşek Ş, Yüksel T, Çim A, Kaya S (2016) Serum cytokine profiles of children with obsessive-compulsive disorders shows the evidence of autoimmunity. Int J Neuropsychopharmacol 19:1–6CrossRef Şimşek Ş, Yüksel T, Çim A, Kaya S (2016) Serum cytokine profiles of children with obsessive-compulsive disorders shows the evidence of autoimmunity. Int J Neuropsychopharmacol 19:1–6CrossRef
26.
go back to reference Tokac D, Tuzun E, Gulec H, Yılmaz V, Bireller ES, Cakmakoglu B, Kucukali CI (2016) Chemokine and chemokine receptor polymorphisms in bipolar disorder. Psychiatry Investig 13:541–548CrossRefPubMedPubMedCentral Tokac D, Tuzun E, Gulec H, Yılmaz V, Bireller ES, Cakmakoglu B, Kucukali CI (2016) Chemokine and chemokine receptor polymorphisms in bipolar disorder. Psychiatry Investig 13:541–548CrossRefPubMedPubMedCentral
27.
go back to reference Han YM, Cheung WK, Wong CK, Sze SL, Cheng TW, Yeung MK, Chan AS (2017) Distinct cytokine and chemokine profiles in autism spectrum disorders. Front Immunol 8:11PubMedPubMedCentral Han YM, Cheung WK, Wong CK, Sze SL, Cheng TW, Yeung MK, Chan AS (2017) Distinct cytokine and chemokine profiles in autism spectrum disorders. Front Immunol 8:11PubMedPubMedCentral
28.
go back to reference Hong S, Lee EE, Martin AS, Soontornniyomkij B, Soontornniyomkij V, Achim CL, Reuter C, Irwin MR, Eyler LT, Jeste DV (2017) Abnormalities in chemokine levels in schizophrenia and their clinical correlates. Schizophr Res 181:63–69CrossRefPubMed Hong S, Lee EE, Martin AS, Soontornniyomkij B, Soontornniyomkij V, Achim CL, Reuter C, Irwin MR, Eyler LT, Jeste DV (2017) Abnormalities in chemokine levels in schizophrenia and their clinical correlates. Schizophr Res 181:63–69CrossRefPubMed
30.
go back to reference Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57:1068–1072CrossRefPubMed Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57:1068–1072CrossRefPubMed
31.
go back to reference Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J, Voshaar RC, Elzinga BM (2011) Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 16:1088–1095CrossRefPubMed Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J, Voshaar RC, Elzinga BM (2011) Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 16:1088–1095CrossRefPubMed
32.
go back to reference Maina G, Rosso G, Zanardini R, Bogetto F, Gennarelli M, Bocchio-Chiavetto L (2010) Serum levels of brain-derived neurotrophic factor in drug naive obsessive-compulsive patients: a case-control study. J Affect Disord 122:174–178CrossRefPubMed Maina G, Rosso G, Zanardini R, Bogetto F, Gennarelli M, Bocchio-Chiavetto L (2010) Serum levels of brain-derived neurotrophic factor in drug naive obsessive-compulsive patients: a case-control study. J Affect Disord 122:174–178CrossRefPubMed
33.
go back to reference Wang Y, Mathews CA, Li Y, Lin Z, Xiao Z (2011) Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients. J Affect Disord 133:305–310CrossRefPubMed Wang Y, Mathews CA, Li Y, Lin Z, Xiao Z (2011) Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients. J Affect Disord 133:305–310CrossRefPubMed
34.
go back to reference Fontenelle LF, Barbosa IG, Luna JV, Rocha NP, Silva Miranda A, Teixeira AL (2012) Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res 199:195–200CrossRefPubMed Fontenelle LF, Barbosa IG, Luna JV, Rocha NP, Silva Miranda A, Teixeira AL (2012) Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res 199:195–200CrossRefPubMed
35.
go back to reference Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, DeJongh R, Bosmans E, Scharpé S (1999) Negative immuno regulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20:370–379CrossRefPubMed Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, DeJongh R, Bosmans E, Scharpé S (1999) Negative immuno regulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20:370–379CrossRefPubMed
36.
go back to reference Kenis G, Maes M (2002) Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacology 5:401–412CrossRef Kenis G, Maes M (2002) Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacology 5:401–412CrossRef
37.
go back to reference Leonard BE, Myint A (2009) The psychoneuroimmunology of depression. Hum Psychopharmacol 24:165–175PubMed Leonard BE, Myint A (2009) The psychoneuroimmunology of depression. Hum Psychopharmacol 24:165–175PubMed
38.
go back to reference Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988CrossRefPubMed Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988CrossRefPubMed
39.
go back to reference Gökler B, Ünal F, Pehlivantürk B, Kültür EÇ, Akdemir D, Taner Y (2004) Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-turkish version (K-SADS-PL-T). Turk J Chıld Adolesc Ment Health 11:109–116 Gökler B, Ünal F, Pehlivantürk B, Kültür EÇ, Akdemir D, Taner Y (2004) Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-turkish version (K-SADS-PL-T). Turk J Chıld Adolesc Ment Health 11:109–116
40.
go back to reference Rachman S, Hodgson RJ (1980) Obsessions and compulsions. Prentice Hall, Englewood Cliffs Rachman S, Hodgson RJ (1980) Obsessions and compulsions. Prentice Hall, Englewood Cliffs
41.
go back to reference Erol N, Savaşır I (1998) Turkish version of Maudsley Obsessive Compulsive Questionnaire. In: paper presented at the meeting of the Turkish National Psychiatry Congress, p 107–114 Erol N, Savaşır I (1998) Turkish version of Maudsley Obsessive Compulsive Questionnaire. In: paper presented at the meeting of the Turkish National Psychiatry Congress, p 107–114
42.
go back to reference Hodgson RJ, Rachman S (1977) Obsessional-Compulsive complaints. Behavioral and research. Therapy 15:389–395 Hodgson RJ, Rachman S (1977) Obsessional-Compulsive complaints. Behavioral and research. Therapy 15:389–395
43.
go back to reference Kovacs M (1985) The Children’s Depression, Inventory (CDI). Psychopharmacol Bull 21:995–998PubMed Kovacs M (1985) The Children’s Depression, Inventory (CDI). Psychopharmacol Bull 21:995–998PubMed
44.
go back to reference Oy B (1991) Children’s depression inventory: a study of reliability and validity. Turk Psychiatry Derg 2:137–140 Oy B (1991) Children’s depression inventory: a study of reliability and validity. Turk Psychiatry Derg 2:137–140
45.
go back to reference Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M (1999) Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry 38:1230–1236CrossRefPubMed Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M (1999) Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry 38:1230–1236CrossRefPubMed
46.
go back to reference Karaceylan F (2005) Reliability and validity of SCARED in Turkish children. Dissertation, Kocaeli University, Kocaeli Karaceylan F (2005) Reliability and validity of SCARED in Turkish children. Dissertation, Kocaeli University, Kocaeli
47.
go back to reference Lin H, Katsovich L, Ghebremichael M, Findley DB, Grantz H, Lombroso PJ, King RA, Zhang H, Leckman JF (2007) Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry 48(2):157–166CrossRefPubMedPubMedCentral Lin H, Katsovich L, Ghebremichael M, Findley DB, Grantz H, Lombroso PJ, King RA, Zhang H, Leckman JF (2007) Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry 48(2):157–166CrossRefPubMedPubMedCentral
48.
go back to reference Lo Faravelli C, Sauro C, Godini L, Lelli L, Benni L, Pietrini F, Lazzeretti L, Talamba GA, Fioravanti G, Ricca V (2012) Childhood stressful events, HPA axis and anxiety disorders. World J Psychiatry 2:13–25CrossRef Lo Faravelli C, Sauro C, Godini L, Lelli L, Benni L, Pietrini F, Lazzeretti L, Talamba GA, Fioravanti G, Ricca V (2012) Childhood stressful events, HPA axis and anxiety disorders. World J Psychiatry 2:13–25CrossRef
49.
go back to reference Blackmore ER, Moynihan JA, Rubinow DR, Pressman EK, Gilchrist M, O’Connor TG (2011) Psychiatric symptoms and proinflammatory cytokines in pregnancy. Psychosom Med 7:656–663CrossRef Blackmore ER, Moynihan JA, Rubinow DR, Pressman EK, Gilchrist M, O’Connor TG (2011) Psychiatric symptoms and proinflammatory cytokines in pregnancy. Psychosom Med 7:656–663CrossRef
50.
go back to reference Danese A, Pariante CM, Caspi A, Taylor A, Poulton R (2007) Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci 4:1319–1324CrossRef Danese A, Pariante CM, Caspi A, Taylor A, Poulton R (2007) Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci 4:1319–1324CrossRef
51.
go back to reference Shaashua L, Sominsky L, Levi B, Sorski L, Reznick M, Page GG, Ben-Eliyahu S (2012) In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: potential mediating mechanisms and sex differences. Brain Behav Immun 26:996–1005CrossRefPubMedPubMedCentral Shaashua L, Sominsky L, Levi B, Sorski L, Reznick M, Page GG, Ben-Eliyahu S (2012) In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: potential mediating mechanisms and sex differences. Brain Behav Immun 26:996–1005CrossRefPubMedPubMedCentral
52.
go back to reference Dhabhar FS, Saul AN, Holmes TH, Daugherty C, Neri E, Tillie JM, Kusewitt D, Oberyszyn TM (2012) High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma. PLoS ONE 7:1–14CrossRef Dhabhar FS, Saul AN, Holmes TH, Daugherty C, Neri E, Tillie JM, Kusewitt D, Oberyszyn TM (2012) High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma. PLoS ONE 7:1–14CrossRef
53.
go back to reference Shaashua L, Rosenne E, Neeman E, Sorski L, Sominsky L, Matzner P, Page GG, Ben-Eliyahu S (2014) Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids. Psychoneuroendocrinology 42:11–23CrossRefPubMedPubMedCentral Shaashua L, Rosenne E, Neeman E, Sorski L, Sominsky L, Matzner P, Page GG, Ben-Eliyahu S (2014) Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids. Psychoneuroendocrinology 42:11–23CrossRefPubMedPubMedCentral
54.
go back to reference Ma X (2001) TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect 3:121–129CrossRefPubMed Ma X (2001) TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect 3:121–129CrossRefPubMed
55.
go back to reference Barbosa IG, Huguet RB, Mendonça VA, Sousa LP, Neves FS, Bauer ME, Teixeira AL (2011) Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Eur Arch Psychiatry Clin Neurosci 261:139–143CrossRefPubMed Barbosa IG, Huguet RB, Mendonça VA, Sousa LP, Neves FS, Bauer ME, Teixeira AL (2011) Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Eur Arch Psychiatry Clin Neurosci 261:139–143CrossRefPubMed
56.
go back to reference Scalzo P, Kummer A, Cardoso F, Teixeira AL (2009) Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson’s disease. J Neuroimmunol 216:122–125CrossRefPubMed Scalzo P, Kummer A, Cardoso F, Teixeira AL (2009) Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson’s disease. J Neuroimmunol 216:122–125CrossRefPubMed
Metadata
Title
Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive–compulsive disorder
Authors
Rukiye Çolak Sivri
Ayhan Bilgiç
İbrahim Kılınç
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
European Child & Adolescent Psychiatry / Issue 8/2018
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-017-1099-3

Other articles of this Issue 8/2018

European Child & Adolescent Psychiatry 8/2018 Go to the issue